Therapeutic non-compliance with insulin in the treatment of diabetes mellitus 2

被引:7
作者
Marquez Contreras, Emilio [1 ]
Martell Claros, Nieves [2 ]
Gil Guillen, Vicente [3 ]
Casado Martinez, Jose Joaquin [1 ]
Luis Martin de Pablos, Jose [1 ]
Ferraro Garcia, Javier [1 ]
Chaves Gonzalez, Rosa [1 ]
Fernandez Ortega, Amalia [1 ]
机构
[1] Unidad Gest Clin Orden, Huelva, Spain
[2] Hosp Clin San Carlos, Med Interna Serv, Madrid, Spain
[3] Univ Med Miguel Hernandez, Alicante, Spain
来源
ATENCION PRIMARIA | 2012年 / 44卷 / 02期
关键词
Diabetes mellitus; Treatment Compliance; Insulin; Primary care; Prospective study; TREATMENT RECOMMENDATIONS; MEDICATION ADHERENCE; IMPROVING ADHERENCE; GLYCEMIC CONTROL; TYPE-2; INTERVENTIONS; POPULATION; PEOPLE; COSTS;
D O I
10.1016/j.aprim.2010.11.013
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To determine the percentage of therapeutic noncompliance among type 2 diabetes patients on treatment with insulin. Design: Prospective multicentre study. Setting: Nine Primary Care Health Centre in Huelva (Spain). Participants: A total of 121 type 2 diabetics, who, in the opinion of their doctor, need to start treatment with insulin or have their insulin treatment modified. Main measurements: Five visits were made (enrolment, 6, 12, 18 and 24 months). The variables analysed were, fasting blood glucose, glycosylated haemoglobin, compliance with insulin treatment, measured by counting insulin units. The percentage compliance (PC) was calculated by (PC = Total No. of insulin units expected to be consumed / Total No. of insulin units that should have been taken x 100). A complier was considered as one who achieved a PC between 80 and 100%. Results: There were 103 evaluable subjects (85.8%) with a mean age of 66.4 (SD 11.6) years, and 45 were male (42.8%). The mean percentage compliance with insulin was 90.9% (95% CI, 84.2-97.6%). At the 6, 12, 18 and 24 months visits it was 92.1% (95% CI, 85.6-98.6%), 92.3, 90.1 and 89.2% (95% CI, 81.7-96.7%), respectively. Overall patient compliance was 74.75% (95% CI, 64.3-85.2%). For the visits, compliance was 82.5% (95% CI, 73.3-91.7%), 77.7%, 73.8% and 71.8% (95% CI, 60.9-82.7%), respectively (P < .05 initial-final). Conclusions: A quarter of the diabetic patients did not comply with their insulin treatment. (c) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 25 条
[1]   Utilization of oral hypoglycemic agents in a drug-insured US population [J].
Boccuzzi, SJ ;
Wogen, J ;
Fox, J ;
Sung, JCY ;
Shah, AB ;
Kim, J .
DIABETES CARE, 2001, 24 (08) :1411-1415
[2]   Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus [J].
Brown, JB ;
Nichols, GA ;
Glauber, HS ;
Bakst, A .
CLINICAL THERAPEUTICS, 1999, 21 (06) :1045-1057
[3]  
de León AC, 2009, REV ESP SALUD PUBLIC, V83, P567
[4]   The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review [J].
Cramer, J. A. ;
Benedict, A. ;
Muszbek, N. ;
Keskinaslan, A. ;
Khan, Z. M. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (01) :76-87
[5]   A systematic review of adherence with medications for diabetes [J].
Cramer, JA .
DIABETES CARE, 2004, 27 (05) :1218-1224
[6]  
Devine Scott, 2010, J Med Econ, V13, P203, DOI 10.3111/13696991003741801
[7]   Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes [J].
Donnelly, L. A. ;
Morris, A. D. ;
Evans, J. M. M. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2007, 100 (06) :345-350
[8]   Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine [J].
Fabunmi, Rosalind ;
Nielsen, Loretta L. ;
Quimbo, Ralph ;
Schroeder, Brock ;
Misurski, Derek ;
Wintle, Matthew ;
Wade, Ron .
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) :777-786
[9]  
Garc?a Navarro M, 2001, MEDICINA 150 NICA BA, V116, P141
[10]  
Guillen V. Gil, 1999, TRATADO EPIDEMIOLOGI, P67